NCT07050667 (SUPCAP) is a NA clinical trial of Cold atmospheric plasma in Hard to Heal Wounds, sponsored by Terraplasma Medical GmbH.

Who is sponsoring NCT07050667?

NCT07050667 is sponsored by Terraplasma Medical GmbH.

What drugs are being tested in NCT07050667?

Interventions in NCT07050667: Cold atmospheric plasma, Placebo treatment.

What condition does NCT07050667 study?

NCT07050667 studies Hard to Heal Wounds, Infected Wound.

Is NCT07050667 still recruiting?

NCT07050667 is currently completed. Last updated 3 July 2025.

Last reviewed 2025-07-03 · How we verify

NCT07050667: SUPCAP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment of Chronic Wounds With Cold Plasma -Plasma Care® vs. Placebo

Completed NA Last updated 3 July 2025

What this trial tests

NA trial testing Cold atmospheric plasma in Hard to Heal Wounds in 70 participants. Completed in 13 December 2024.

Timeline

1 May 2023

Primary endpoint
13 December 2024

13 December 2024

Quick facts

Lead sponsor	Terraplasma Medical GmbH
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	70
Start date	1 May 2023
Primary completion	13 December 2024
Estimated completion	13 December 2024
Sites	2 locations across Austria

Drugs / interventions tested

Cold atmospheric plasma
Placebo treatment

Conditions studied

Hard to Heal Wounds — all drugs for Hard to Heal Wounds →
Infected Wound — all drugs for Infected Wound →

Sponsor

Terraplasma Medical GmbH

Who can join

Adults 18 to 95, any sex, with Hard to Heal Wounds or Infected Wound. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: The study aimed to evaluate the wound healing effects of plasma care®, a cold atmospheric plasma device, in patients with chronic wounds. Method: A prospective, multicenter, two-arm, randomized, single-blind clinical trial was conducted to compare the effectiveness of plasma care® versus placebo, both combined with best practice wound care.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Unraveling Chronic Pain: From Mechanisms and Risks to Diagnosis and Treatment.
Dai X, Wang C, Jiang P, Mei X. · · 2026 · PMID 41930351 · DOI 10.1002/mco2.70685

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07050667 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Terraplasma Medical GmbH
Last refreshed: 3 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07050667.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing